Hangzhou Jiebai Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

5.7%

Borç/özkaynak oranı

CN¥268.21m

Borç

Faiz karşılama oranı	-3.2x
Nakit	CN¥5.02b
Eşitlik	CN¥4.68b
Toplam yükümlülükler	CN¥3.84b
Toplam varlıklar	CN¥8.52b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Hangzhou Jiebai Group Co., Limited (SHSE:600814) Looks Inexpensive But Perhaps Not Attractive Enough

Oct 06

Estimating The Fair Value Of Hangzhou Jiebai Group Co., Limited (SHSE:600814)

Apr 30

Hangzhou Jiebai Group Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.059 (vs CN¥0.10 in 3Q 2023)

Hangzhou Jiebai Group Co., Limited (SHSE:600814) Looks Inexpensive But Perhaps Not Attractive Enough

Hangzhou Jiebai Group Co., Limited to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 19%

Second quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.092 in 2Q 2023)

Now 20% undervalued after recent price drop

Hangzhou Jiebai Group Co., Limited to Report First Half, 2024 Results on Aug 30, 2024

Dividend of CN¥0.14 announced

Hangzhou Jiebai Group Co., Limited, Annual General Meeting, May 23, 2024

Estimating The Fair Value Of Hangzhou Jiebai Group Co., Limited (SHSE:600814)

First quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.16 in 1Q 2023)

Hangzhou Jiebai Group Co., Limited to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings released: EPS: CN¥0.36 (vs CN¥0.33 in FY 2022)

Investor sentiment deteriorates as stock falls 19%

Investor sentiment deteriorates as stock falls 16%

Hangzhou Jiebai Group Co., Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Third quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.13 in 3Q 2022)

Hangzhou Jiebai Group Co., Limited to Report Q3, 2023 Results on Oct 26, 2023

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 24%

Second quarter 2023 earnings released: EPS: CN¥0.092 (vs CN¥0.072 in 2Q 2022)

Now 20% undervalued

Full year 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.49 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.056 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.07 (vs CN¥0.13 in 2Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.19 in 1Q 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.14 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.37 (vs CN¥0.33 in FY 2019)

New 90-day low: CN¥5.12

Hangzhou Jiebai Group Co., Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

New 90-day low: CN¥5.46

New 90-day low: CN¥5.74

Third quarter 2020 earnings released: EPS CN¥0.14

Hangzhou Jiebai Group Co., Limited to Report Q3, 2020 Results on Oct 30, 2020

New 90-day low: CN¥5.97

First half earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin